Advanced search×

Neurological manifestations of primary Sjogren's syndrome.

Curr Opin Neurol 23(5):509-13 (2010) PMID 20689426

This review summarizes our current understanding of the neurological manifestations of primary Sjogren's syndrome (PSS), their pathophysiology, and treatment.

DOI: 10.1097/WCO.0b013e32833de6ab
Version: za2963e q8za3 q8zb2 q8zc2 q8zd0 q8ze9 q8zf4 q8zg8

Similar articles you may find interesting…

  1. Punctal plugs versus artificial tears for treating primary Sjögren's syndrome with keratoconjunctivitis SICCA: a comparative observation of ...

    Rheumatol Int (2013) PMID 23649850

    I (STI) and contrast sensitivity was performed before treatment and was repeated 3 months after treatment. A follow-up of 3 months was achieved in 40 eyes of 40 patients, including 19 eyes in artificial tears group and 21 eyes in punctal plugs group. Statistically significant improvements were obs...
  2. A pilot study investigating the effect of Caralluma fimbriata extract on the risk factors of metabolic syndrome in overweight and obese subj...

    Complement Ther Med 21(3):180-9 (2013) PMID 23642949

    Central obesity is a key component of metabolic syndrome and it is often associated with other risk factors such as dyslipidemia, elevated plasma glucose levels and elevated blood pressure (BP). In this pilot study, the effect of Caralluma fimbriata (an edible succulent) extract in c...
  3. A Randomized Clinical Trial Comparing an Acceptance-Based Behavior Therapy to Applied Relaxation for Generalized Anxiety Disorder.

    J Consult Clin Psychol (2013) PMID 23647281

    Mixed effect regression models showed significant, large effects for time for all primary outcome measures (ds = 1.27 to 1.61) but nonsignificant, small effects for condition and Condition × Time (ds = 0.002 to 0.20), indicating that clients in the 2 treatments improved comparably over treatment. F...